120 related articles for article (PubMed ID: 15684490)
1. Intestinal expression and metabolic activity of the CYP3A subfamily in female rats.
Aiba T; Yoshinaga M; Ishida K; Takehara Y; Hashimoto Y
Biol Pharm Bull; 2005 Feb; 28(2):311-5. PubMed ID: 15684490
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine.
Takara K; Ohnishi N; Horibe S; Yokoyama T
Drug Metab Dispos; 2003 Oct; 31(10):1235-9. PubMed ID: 12975332
[TBL] [Abstract][Full Text] [Related]
3. Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats.
Konno Y; Sekimoto M; Nemoto K; Degawa M
Toxicol Appl Pharmacol; 2004 Apr; 196(1):20-8. PubMed ID: 15050404
[TBL] [Abstract][Full Text] [Related]
4. CYP3A in horse intestines.
Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
[TBL] [Abstract][Full Text] [Related]
5. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver.
Mahnke A; Strotkamp D; Roos PH; Hanstein WG; Chabot GG; Nef P
Arch Biochem Biophys; 1997 Jan; 337(1):62-8. PubMed ID: 8990268
[TBL] [Abstract][Full Text] [Related]
6. Poor correlation between intestinal and hepatic metabolic rates of CYP3A4 substrates in rats.
Aiba T; Takehara Y; Okuno M; Hashimoto Y
Pharm Res; 2003 May; 20(5):745-8. PubMed ID: 12751629
[TBL] [Abstract][Full Text] [Related]
7. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
[TBL] [Abstract][Full Text] [Related]
8. Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: implication for cyclosporine metabolism.
Jäger W; Correia MA; Bornheim LM; Mahnke A; Hanstein WG; Xue L; Benet LZ
Drug Metab Dispos; 1999 Dec; 27(12):1505-11. PubMed ID: 10570034
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization and differential expression of cytochrome P450 3A27 in the gastrointestinal tract of rainbow trout.
Lee SJ; Hedstrom OR; Fischer K; Wang-Buhler JL; Sen A; Cok I; Buhler DR
Toxicol Appl Pharmacol; 2001 Dec; 177(2):94-102. PubMed ID: 11740908
[TBL] [Abstract][Full Text] [Related]
10. Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats.
Rowlands JC; Wang H; Hakkak R; Ronis MJ; Strobel HW; Badger TM
J Pharmacol Exp Ther; 2000 Nov; 295(2):747-52. PubMed ID: 11046114
[TBL] [Abstract][Full Text] [Related]
11. Diets containing soy protein isolate increase hepatic CYP3A expression and inducibility in weanling male rats exposed during early development.
Ronis MJ; Chen Y; Jo CH; Simpson P; Badger TM
J Nutr; 2004 Dec; 134(12):3270-6. PubMed ID: 15570024
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2.
Kawai M; Bandiera SM; Chang TK; Bellward GD
Biochem Pharmacol; 2000 May; 59(10):1277-87. PubMed ID: 10736428
[TBL] [Abstract][Full Text] [Related]
13. Insights into gender bias: rat cytochrome P450 3A9.
Anakk S; Ku CY; Vore M; Strobel HW
J Pharmacol Exp Ther; 2003 May; 305(2):703-9. PubMed ID: 12606633
[TBL] [Abstract][Full Text] [Related]
14. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats.
Morita K; Maeda Y; Masuda M; Kazusaka A; Imaoka S; Funae Y; Fujita S
Biochem Pharmacol; 1998 May; 55(9):1405-11. PubMed ID: 10076532
[TBL] [Abstract][Full Text] [Related]
15. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.
Perloff MD; von Moltke LL; Greenblatt DJ
Xenobiotica; 2004 Feb; 34(2):133-50. PubMed ID: 14985144
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat.
Matsubara T; Kim HJ; Miyata M; Shimada M; Nagata K; Yamazoe Y
J Pharmacol Exp Ther; 2004 Jun; 309(3):1282-90. PubMed ID: 15004215
[TBL] [Abstract][Full Text] [Related]
17. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
18. Role of temperature on protein and mRNA cytochrome P450 3A (CYP3A) isozymes expression and midazolam oxidation by cultured rat precision-cut liver slices.
Rekka E; Evdokimova E; Eeckhoudt S; Labar G; Calderon PB
Biochem Pharmacol; 2002 Aug; 64(4):633-43. PubMed ID: 12167482
[TBL] [Abstract][Full Text] [Related]
19. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
[TBL] [Abstract][Full Text] [Related]
20. Hepatic and intestinal CYP3A expression and activity in broilers.
Osselaere A; De Bock L; Eeckhaut V; De Backer P; Van Bocxlaer J; Boussery K; Croubels S
J Vet Pharmacol Ther; 2013 Dec; 36(6):588-93. PubMed ID: 23330986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
